Profiling of differentially expressed genes in LRRC4 overexpressed glioblastoma cells by cDNA array

Qiu-Hong Zhang1, Ming-Hua Wu, Li-Li Wang

  • 1Cancer Research Institute, Central South University, Changsha 410078, China.

Insights

Leucine-rich repeat-containing protein 4 (LRRC4) suppresses brain tumor growth by altering neurobiological gene expression. This study reveals LRRC4

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Gene Expression Analysis

Background:

  • Leucine-rich repeat-containing protein 4 (LRRC4) is a novel leucine-rich repeat (LRR) superfamily member.
  • Previous research indicated LRRC4's potential in suppressing brain tumor growth.
  • Understanding LRRC4's role in central nervous system (CNS) function and tumorigenesis requires further investigation.

Purpose of the Study:

  • To investigate the functional impact of LRRC4 on neurobiological gene expression.
  • To analyze LRRC4's effects on glioblastoma cell line U251MG.
  • To explore LRRC4's role in maintaining normal CNS function and suppressing tumorigenesis.

Main Methods:

  • Utilized Atlas array technology to analyze gene expression in LRRC4-overexpressing U251MG Tet-on cells.
  • Investigated alterations in 588 neurobiology-related genes.
  • Performed cell invasion assays to assess LRRC4's effect on cell migration.

Main Results:

  • Seventeen out of 588 genes exhibited altered expression levels in LRRC4-transfected cells.
  • Affected genes are involved in critical cellular processes including proliferation, cell cycle, tumor invasion, metastasis, and neurotransmitter synthesis/release.
  • LRRC4 demonstrated an inhibitory effect on U251MG cell migration.

Conclusions:

  • This study represents the first cDNA array analysis of LRRC4's effects on neurobiological genes in U251MG glioblastoma cells.
  • LRRC4 influences key pathways related to glioblastoma progression.
  • LRRC4 provides new insights into glioma pathogenesis and potential therapeutic strategies.